Clinical significance of loss of heterozygosity for M6P/IGF2R in patients with primary hepatocellular carcinoma

World Journal of Gastroenterology

Volumn 14, Issue 9, 2008, Pages 1394-1398

  Jang, Hong Seok ^a   Kang, Ki Mun ^b   Choi, Byung Ock ^a   Chai, Gyu Young ^b   Hong, Soon Chan ^c   Ha, Woo Song ^c   Jirtle, Randy L ^d  

^a The Catholic University of Korea   (South Korea)

^b Gyeongsang National University   (South Korea)

^c Gyeongsang National University School of Medicine   (South Korea)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Hepatocellular carcinoma; Loss of heterozygosity; Mannose 6 phosphate insulin like growth factor 2 receptor

Indexed keywords

MANNOSE 6 PHOSPHATE; NUCLEOTIDE; SOMATOMEDIN B RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GENETIC POLYMORPHISM; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER RESECTION; MALE; OVERALL SURVIVAL; PREDICTION; PROGNOSIS; TREATMENT OUTCOME;

EID: 41149151320     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.1394     Document Type: Article

References (30)

1. Bartlett DL. Cancer of the liver. In: DeVita VT Jr, Hell-man S, Rosenberg SA. Cancer: Principles & Practice of Oncology. Philadelphia: Lippincott, 2005: 986-1009
2. Groopman JD, Wogan GN, Roebuck BD, Kensler TW. Molecular biomarkers for aflatoxins and their application to human cancer prevention. Cancer Res 1994; 54: 1907s-1911s
3. Laureys G, Barton DE, Ullrich A, Francke U. Chromosomal mapping of the gene for the type II insulin-like growth factor receptor/ cation-independent mannose 6-phosphate receptor in man and mouse. Genomics 1988; 3: 224-229
4. Buendia MA. Genetics of hepatocellular carcinoma. Semin Cancer Biol 2000; 10: 185-200
5. Jirtle RL. Mannose 6-phosphate receptors. In: Creidton TE. Encyclopedia of Molecular Biology. New York: Wiley-Liss, 1999: 1441-1447
6. Motyka B, Korbutt G, Pinkoski MJ, Heibein JA, Caputo A, Hobman M, Barry M, Shostak I, Sawchuk T, Holmes CF, Gauldie J, Bleackley RC. Mannose 6-phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T cell-induced apoptosis. Cell 2000; 103: 491-500
7. Filson AJ, Louvi A, Efstratiadis A, Robertson EJ. Rescue of the T-associated maternal effect in mice carrying null mutations in Igf-2 and Igf2r, two reciprocally imprinted genes. Development 1993; 118: 731-736
8. Young LE, Fernandes K, McEvoy TG, Butterwith SC, Gutierrez CG, Carolan C, Broadbent PJ, Robinson JJ, Wilmut I, Sinclair KD. Epigenetic change in IGF2R is associated with fetal overgrowth after sheep embryo culture. Nat Genet 2001; 27: 153-154
9. Yamada T, De Souza AT, Finkelstein S, Jirtle RL. Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis. Proc Natl Acad Sci USA 1997; 94: 10351-10355
10. Kong FM, Anscher MS, Washington MK, Killian JK, Jirtle RL. M6P/ IGF2R is mutated in squamous cell carcinoma of the lung. Oncogene 2000; 19: 1572-1578
11. Ouyang H, Shiwaku HO, Hagiwara H, Miura K, Abe T, Kato Y, Ohtani H, Shiiba K, Souza RF, Meltzer SJ, Horii A. The insulin-like growth factor II receptor gene is mutated in genetically unstable cancers of the endometrium, stomach, and colorectum. Cancer Res 1997; 57: 1851-1854
12. Hankins GR, De Souza AT, Bentley RC, Patel MR, Marks JR, Iglehart JD, Jirtle RL. M6P/IGF2 receptor: a candidate breast tumor suppressor gene. Oncogene 1996; 12: 2003-2009
13. Souza RF, Wang S, Thakar M, Smolinski KN, Yin J, Zou TT, Kong D, Abraham JM, Toretsky JA, Meltzer SJ. Expression of the wild-type insulin-like growth factor II receptor gene suppresses growth and causes death in colorectal carcinoma cells. Oncogene 1999; 18: 4063-4068
14. Chen Z, Ge Y, Landman N, Kang TX. Decreased expression of the mannose 6-phosphate/insulin-like growth factor-II receptor promotes growth of human breast cancer cells. BMC Cancer 2002; 2: 18
15. Lu ZL, Luo DZ, Wen JM. Expression and significance of tumor-related genes in HCC. World J Gastroenterol 2005; 11: 3850-3854
16. Kang JX, Bell J, Beard RL, Chandraratna RA. Mannose 6-phosphate/ insulin-like growth factor II receptor mediates the growth-inhibitory effects of retinoids. Cell Growth Differ 1999; 10: 591-600
17. Clurman B, Groudine M. Tumour-suppressor genes. Killer in search of a motive? Nature 1997; 389: 122-123
18. De Souza AT, Hankins GR, Washington MK, Fine RL, Orton TC, Jirtle RL. Frequent loss of heterozygosity on 6q at the mannose 6-phosphate/ insulin-like growth factor II receptor locus in human hepatocellular tumors. Oncogene 1995; 10: 1725-1729
19. Oka Y, Waterland RA, Killian JK, Nolan CM, Jang HS, Tohara K, Sakaguchi S, Yao T, Iwashita A, Yata Y, Takahara T, Sato S, Suzuki K, Masuda T, Jirtle RL. M6P/IGF2R tumor suppressor gene mutated in hepatocellular carcinomas in Japan. Hepatology 2002; 35: 1153-1163
20. De Souza AT, Hankins GR, Washington MK, Orton TC, Jirtle RL. M6P/ IGF2R gene is mutated in human hepatocellular carcinomas with kiss of heterozygosity. Nat Genet 1995; 11: 447-449
21. Souza RF, Appel R, Yin J, Wang S, Smolinski KN, Abraham JM, Zou TT, Shi YQ, Lei J, Cottrell J, Cymes K, Biden K, Simms L, Leggett B, Lynch PM, Frazier M, Powell SM, Harpaz N, Sugimura H, Young J, Meltzer SJ. Microsatellite instability in the insulin-like growth factor II receptor gene in gastrointestinal tumours. Nat Genet 1996; 14: 255-257
22. Osipo C, Dorman S, Frankfater A. Loss of insulin-like growth factor II receptor expression promotes growth in cancer by increasing intracellular signaling from both IGF-I and insulin receptors. Exp Cell Res 2001; 264: 388-396
23. Robinson WP. Mechanisms leading to uniparental disomy and their clinical consequences. Bioessays 2000; 22: 452-459
24. Barlow DP, Stoger R, Herrmann BG, Saito K, Schweifer N. The mouse insulin-like growth factor type-2 receptor is imprinted and closely linked to the Tme locus. Nature 1991; 349: 84-87
25. Killian JK, Nolan CM, Wylie AA, Li T, Vu TH, Hoffman AR, Jirtle RL. Divergent evolution in M6P/IGF2R imprinting from the Jurassic to the Quaternary. Hum Mol Genet 2001; 10: 1721-1728
26. Wutz A, Theussl HC, Dausman J, Jaenisch R, Barlow DP, Wagner EF. Non-imprinted Igf2r expression decreases growth and rescues the Tme mutation in mice. Development 2001; 128: 1881-1887
27. Islam MQ, Islam K. A new functional classification of tumor-suppressing genes and its therapeutic implications. Bioessays 2000; 22: 274-285
28. Quon KC, Berns A. Haplo-insufficiency? Let me count the ways. Genes Dev 2001; 15: 2917-2921
29. Lynch CJ, Milner J. Loss of one p53 allele results in four-fold reduction of p53 mRNA and protein: a basis for p53 haplo-insufficiency. Oncogene 2006; 25: 3463-3470
30. Jirtle RL. Genomic imprinting and cancer. Exp Cell Res 1999; 248: 18-24